PROMPT:

Assessment: Follow-up in 3 months

RESPONSE (Sentence ending after 60th word):

)  Clinical remission was seen in all participants. No patients were required to restart the medication or lose weight, which was a positive development for the study and is a step towards finding a treatment for weight-related diseases as well as preventing their occurrence in the first place. The trial was also encouraging. Although patients lost 5% of the initial weight during the trial, their average BMI did not return to the pre-treatment level in any of the groups. 